NY-based Silna, which provides healthcare revenue cycle management software, emerges from stealth with a $22M Series A co-led by Accel and Bain and a $5M seed
the company I cofounded w @Jeffrey_Morelli and @sagarjajoo—is emerging with $27M in funding from Accel+Bain Capital Our platform is already enabling tens of thousands of patients to access critical care Here's how we got here ⬇️ [image] Ryan Sandler / @ryansandler_ : Silna is a clear example of LLMs unlocking a huge vertical - prior authorization- that simply wasn't possible to go after before Fired up for this team Pavel Asparouhov / @pavel_asparagus : Jeff and I grew up in SLC and stayed in touch I knew he'd led GTM at TrueWork to 10s of millions in revenue, where Sagar (an early employee at multiple Unicorns) was his partner in crime Jeff knew I'd built Ramp's Bill Pay from 0 to billions We knew we had to work together [image] Nik Koblov / @koblovinamerica : If you ever wondered how to build the most relevant healthtech company that focuses on the most important part in healthtech - the patient, @Pavel_Asparagus tells a compelling story that's worth a read in this 🧵. Congrats on the raise and i can't wait to use the platform now Delian / @zebulgar : Building badass companies runs in the family Congrats to Pavel, Jeff and Sagar on their launch today, and their $27m of funding!!
Context & Ripple Effects
Healthcare software funding in the related coverage has spanned patient access and provider operations, from Solv's urgent-care patient-management financing to Stellar Health's value-based-care tools. Silna narrows that focus to prior authorization, a revenue-cycle workflow its founders say LLMs can address.
The financing also fits a later cluster of AI-led financial-operations products in healthcare, including Candid Health's billing and claims automation funding and Translucent's hospital-finance tools. Silna's distinction is its stated emphasis on authorization before care is delivered.
First-order effects
- Silna gains $22M in Series A capital, following its $5M seed, to build and deploy its healthcare revenue-cycle platform with Accel and Bain Capital as co-leads.
- Providers and patients using Silna's platform may get a more automated path through prior authorization; the company says the platform already supports access to critical care for tens of thousands of patients.
Second-order effects
- Healthcare revenue-cycle vendors focused on manual authorization work face added pressure to demonstrate that their products can incorporate LLM-driven workflow automation rather than only digitize existing processes.
- The investment sharpens attention on the boundary between authorization, billing and hospital-finance software, where Translucent's AI finance tooling and Candid's claims-focused agents address adjacent operational budgets.
Third-order effects
- If LLM-based prior-authorization systems prove reliable in production, value in healthcare administration could shift from point workflow software toward platforms that connect patient access with revenue-cycle operations.
- That shift remains contingent on adoption by providers and on whether automation can handle the operational and oversight demands of authorization workflows at scale.
The trend: Healthcare AI funding is increasingly targeting discrete administrative bottlenecks where automation can be tied to provider operations and patient access.